Ausgabe 5/2017
Inhalt (31 Artikel)
Cost effective measures to standardize serum 25(OH)D values from completed studies
C. T. Sempos, R. A. Durazo-Arvizu, G. D. Carter
Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures
N. C. W. Harvey, E. V. McCloskey, P. J. Mitchell, B. Dawson-Hughes, D. D. Pierroz, J.-Y. Reginster, R. Rizzoli, C. Cooper, J. A. Kanis
Worldwide prevalence and incidence of osteoporotic vertebral fractures
G. Ballane, J. A. Cauley, M. M. Luckey, G. El-Hajj Fuleihan
Hyponatremia and fractures: should hyponatremia be further studied as a potential biochemical risk factor to be included in FRAX algorithms?
J. C. Ayus, T. Bellido, A. L. Negri
Post-fracture care: do we need to educate patients rather than doctors? The PREVOST randomized controlled trial
B. Merle, R. Chapurlat, E. Vignot, T. Thomas, J. Haesebaert, A.-M. Schott
Effect of comorbidities on the association between age and hospital mortality after fall-related hip fracture in elderly patients
A. Padrón-Monedero, T. López-Cuadrado, I. Galán, E. V. Martínez-Sánchez, P. Martin, R. Fernández-Cuenca
The association between sarcopenia and functional outcomes among older patients with hip fracture undergoing in-hospital rehabilitation
F. Landi, R. Calvani, E. Ortolani, S. Salini, A. M. Martone, L. Santoro, A. Santoliquido, A. Sisto, A. Picca, E. Marzetti
Dietary potassium intake is beneficial to bone health in a low calcium intake population: the Korean National Health and Nutrition Examination Survey (KNHANES) (2008–2011)
S. H. Kong, J. H. Kim, A. R. Hong, J. H. Lee, S. W. Kim, C. S. Shin
Use of proton pump inhibitors and mortality after hip fracture in a nationwide study
W. Brozek, B. Reichardt, J. Zwerina, H. P. Dimai, K. Klaushofer, E. Zwettler
The importance of physical function to people with osteoporosis
C. Kerr, C. Bottomley, S. Shingler, L. Giangregorio, H. M. de Freitas, C. Patel, S. Randall, D. T. Gold
Preceding and subsequent high- and low-trauma fracture patterns—a 13-year epidemiological study in females and males in Austria
C. Muschitz, R. Kocijan, A. Baierl, R. Dormann, X. Feichtinger, J. Haschka, M. Szivak, G. K. Muschitz, J. Schanda, P. Pietschmann, H. Resch, H. P. Dimai
Adipokines may mediate the relationship between resting metabolic rates and bone mineral densities in obese women
S. Moradi, K. Mirzaei, A. A. Abdurahman, S. A. Keshavarz
Association of DPP-4 activity with BMD, body composition, and incident hip fracture: the Cardiovascular Health Study
L. D. Carbone, P. Bůžková, H. A. Fink, J. A. Robbins, M. Bethel, C. M. Isales, W. D. Hill
The associations between serum 25-hydroxyvitamin D level and the risk of total fracture and hip fracture
Y. Feng, G. Cheng, H. Wang, B. Chen
Standardizing 25-hydroxyvitamin D data from the HunMen cohort
E. Jakab, E. Kalina, Z. Petho, Z. Pap, A. Balogh, W. B. Grant, H. P. Bhattoa
Validity of height loss as a predictor for prevalent vertebral fractures, low bone mineral density, and vitamin D deficiency
A. L. Mikula, S. J. Hetzel, N. Binkley, P. A. Anderson
Skeletal effects of vitamin D deficiency among patients with primary hyperparathyroidism
J. H. Lee, J. H. Kim, A. R. Hong, S. W. Kim, C. S. Shin
Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities
I. D. B. Marques, M. J. C. L. N. Araújo, F. G. Graciolli, L. M . dos Reis, R. M. Pereira, M. R. Custódio, V. Jorgetti, R. M. Elias, E. David-Neto, R. M. A. Moysés
Evaluation of bone mineral density and microarchitectural parameters by DXA and HR-pQCT in 37 children and adults with X-linked hypophosphatemic rickets
G. P. Colares Neto, R. M. R. Pereira, J. C. Alvarenga, L. Takayama, M. F. A. Funari, R. M. Martin
Bone mass loss is associated with systolic blood pressure in postmenopausal women with type 2 diabetes in Tibet: a retrospective cross-sectional study
L. Zhou, J. Song, S. Yang, S. Meng, X. Lv, J. Yue, A. Mina, B. Puchi, Y. Geng, L. Yang
Socioeconomic status and bone mineral density in adults by race/ethnicity and gender: the Louisiana osteoporosis study
Y. Du, L.-J. Zhao, Q. Xu, K-H. Wu, H.-W. Deng
Increased risk of incident osteoporosis and osteoporotic fracture in tuberculosis patients: a population-based study in a tuberculosis-endemic area
Y.-Y. Chen, J.-Y. Feng, W.-Y. Ting, Y.-F. Yen, P.-H. Chuang, S.-W. Pan, V. Y.-F. Su, W.-J. Su
Observations following discontinuation of long-term denosumab therapy
M. R. McClung, R. B. Wagman, P. D. Miller, A. Wang, E. M. Lewiecki
Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan
T. Mori, C. J. Crandall, D. A. Ganz
Pharmacokinetics of coadministration of levothyroxine sodium and alendronate sodium new effervescent formulation
H. G. Bone, M. A. Walter, M. E. Hurley, S. Epstein
Conclusions stand firm with additional data
C. M. Weaver, B. Dawson-Hughes, J. M. Lappe, T. C. Wallace
Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients: response to comments
M. Kamimura, Y. Nakamura, S. Ikegami, S. Uchiyama, H. Kato, A. Taguchi
Response to: A role for thiazide diuretic therapy in preventing bone loss, fracture and nephrolithiasis in individuals with thalassemia and hypercalciuria?
A. D. Dede, G. Trovas, E. Chronopoulos, I. K. Triantafyllopoulos, I. Dontas, N. Papaioannou, S. Tournis
Erratum to: Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis
S.-H. Lee, W.-T. Hsu, C.-C. Lai, A. Esmaily-Fard, Y.-W. Tsai, C.-C. Chiu, J. Wang, S.-S. Chang, C. C. Lee